|
Abrisqueta M, Cerdido S, Sanchez-Beltran J, Martinez-Vicente I, Herraiz C, Lambertos A, Olivares C, Sevilla A, Alonso S, Boyano MD, Garcia-Borron JC, Jimenez-Cervantes C. MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker. Life (Basel). 2022 Jul 26;12(8):1118. doi: 10.3390/life12081118. PubMed PMID: 35892921; PubMed Central PMCID: PMC9331370.
AÑO: 2022; IF: 3.251
|
35892921
|
Cerdido S, Abrisqueta M, Sanchez-Beltran J, Lambertos A, Castejon-Grinan M, Munoz C, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C, Herraiz C. MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42. Cancer Lett. 2024 Jan 28;581:216484. doi: 10.1016/j.canlet.2023.216484. Epub 2023 Nov 25. PubMed PMID: 38008393.
AÑO: 2024; IF: 9.1
|
|
Castejon-Grinan M, Cerdido S, Sanchez-Beltran J, Lambertos A, Abrisqueta M, Herraiz C, Jimenez-Cervantes C, Garcia-Borron JC. Melanoma-associated melanocortin 1 receptor variants confer redox signaling-dependent protection against oxidative DNA damage. Redox Biol. 2024 Jun;72:103135. doi: 10.1016/j.redox.2024.103135. Epub 2024 Mar 26. PubMed PMID: 38565069; PubMed Central PMCID: PMC11002308.
AÑO: 2024; IF: 10.7
|